Related Experiment Video
Updated: Jul 12, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Neuropathological postmortem evaluation of BNCT for GBM.
B H-Stenstam1, L Pellettieri, K Sköld
1Nyköping Hospital, County of Sormland, Sweden.
Acta Neurologica Scandinavica
|August 24, 2007
Summary
Boron neutron capture therapy (BNCT) effectively controls glioblastoma multiforme (GBM) brain tumors. This study found BNCT achieved local tumor control with minimal radiation damage to surrounding healthy brain tissue.
Area of Science:
- Oncology
- Radiation Oncology
- Neurosurgery
Background:
- A clinical trial investigated boron neutron capture therapy (BNCT) for glioblastoma multiforme (GBM).
- Thirty patients received BNCT using a novel procedure involving p-boronophenylalanine (BPA) infusion.
- The study focused on neuropathological examination of seven patients from the trial.
Observation:
- The study assessed tumor efficacy and radiation-induced brain damage in GBM patients treated with BNCT.
- Postmortem neuropathological examination was conducted on available patient samples.
- Microscopy and immunological methods were used to analyze brain tissue.
Findings:
- Boron neutron capture therapy (BNCT) demonstrated local control of glioblastoma multiforme (GBM) in all examined cases.
- No conclusive evidence of radiation-induced brain damage was identified.
- Effective GBM treatment was achieved with minimal doses to surrounding healthy tissues.
Implications:
- BNCT offers a promising therapeutic strategy for glioblastoma multiforme.
- The novel BPA infusion procedure allows for effective tumor control with reduced toxicity.
- This approach may improve outcomes for GBM patients by minimizing damage to healthy brain tissue.
